已收盤 09-06 16:00:00 美东时间
-0.390
-3.32%
ARS Pharmaceuticals Inc : Leerink Partners Raises Target Price to $21 From $20
08-27 12:09
ARS Pharmaceuticals's (NYSE:SPRY) short percent of float has risen 13.47% since...
08-20 01:30
绩后飙涨24%!星巴克“换帅”获华尔街集体看好!ESOA单日暴涨37%,第三财季盈利增长逾5倍>>
08-14 19:10
Lexicon Pharmaceuticals (NASDAQ:LXRX) plans to cut around 50% of its workforce, or more than 75 jobs, to prioritize commercialization of its drug sotagliflozin, also known as Inpefa and Zynquista. The...
08-13 22:17
ARS Pharmaceuticals Inc : Raymond James Raises Target Price to $22 From $18
08-13 19:20
ARS Pharmaceuticals Inc : Raymond James Raises to Strong Buy From Outperform
08-13 19:19
Raymond James analyst Ryan Deschner upgrades ARS Pharmaceuticals (NASDAQ:SPRY) from Outperform to Strong Buy and raises the price target from $18 to $22.
08-13 17:35
An announcement from ARS Pharmaceuticals (SPRY) is now available. ARS Pharmaceu...
08-13 09:17
ARS Pharmaceuticals Exec Says Expect to Make Neffy Available in Europe Later Th...
08-12 20:19
ARS Pharmaceuticals Exec Says Expect to File Supplemental Marketing Application...
08-12 20:17